Diametric Capital, LP Athenex, Inc. Transaction History

Diametric Capital, LP

  • $173 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020
SELL
$10.26 - $14.55 $124,248 - $176,200
-12,110 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$7.11 - $13.76 $1,649 - $3,192
232 Added 1.95%
12,110 $167,000
Q1 2020

May 15, 2020
SELL
$5.71 - $15.85 $253,701 - $704,231
-44,431 Reduced 78.91%
11,878 $92,000
Q4 2019

Feb 14, 2020
BUY
$9.6 - $17.75 $540,566 - $999,484
56,309 New
56,309 $860,000

Others Institutions Holding ATNX

# of Institutions
3
Shares Held
1.46M
Call Options Held
0
Put Options Held
0
View Full List

About Athenex, Inc.

ATNX Quotes by TradingView
  • Ticker ATNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 156,790,000
  • Market Cap $1.57M
  • Description
  • Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...
More about ATNX
Track This Portfolio

Track Diametric Capital, LP Portfolio

Follow Diametric Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diametric Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Diametric Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email